Table 1 Preoperative and postoperative fibroscan scores of 111 bariatric surgery patients with MASLD.

From: The early impact of bariatric surgery on metabolic dysfunction-associated steatotic liver disease (MASLD) as assessed by fibroscan at 6 months postoperatively

CAP (dB/m)

Before Bariatric Surgery

After Bariatric Surgery

Mean Reduction

p value*

355 ± 41

262 ± 52

26%

< 0.001

LSM (kPa)

8.3 ± 6

5.6 ± 3.7

33%

< 0.001

BMI (kg/m2)

49 ± 7

35 ± 6

28%

< 0.001

 

Total (%)

Total (%)

Normalisation rate

p value**

CAP > 240

111 (100%)

68 (61%)

39%

< 0.001

LSM > 7

45 (41%)

9 (8%)

80%

< 0.001

LSM > 12

18 (16%)

5 (4.5%)

72%

0.002

  1. Data are presented as frequency (%) or mean (SD)
  2. CAP Controlled Attenuation Parameter; LSM Liver Stiffness Measurement; BMI Body Mass Index
  3. *Paired t-test or Wilcoxon signed-rank test **McNemar’s test
Back to article page